Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Cancer immunotherapy by immune checkpoint blockade has proven its great potential by saving the lives of a proportion of late stage patients with immunogenic tumor types. However, even in these sensitive tumor types, the majority of patients do not sufficiently respond to the therapy. Furthermore, o...
Main Authors: | Ana Rita Pombo Antunes, Isabelle Scheyltjens, Johnny Duerinck, Bart Neyns, Kiavash Movahedi, Jo A Van Ginderachter |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-02-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/52176 |
Similar Items
-
The Interplay between Glioblastoma and Its Microenvironment
by: Mark Dapash, et al.
Published: (2021-08-01) -
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
by: Niklas Zimmer, et al.
Published: (2019-07-01) -
Immune Microenvironment in Glioblastoma Subtypes
by: Zhihong Chen, et al.
Published: (2018-05-01) -
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
by: Jun Ma, et al.
Published: (2021-05-01) -
Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
by: Francesca Napoli, et al.
Published: (2021-05-01)